ArticleNPJ precision oncology2023

BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study.

Blessie Elizabeth Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.